Cancer Registry Software Market
According to Intent Market Research, the Cancer Registry Software Market is expected to grow from USD 2.6 billion in 2023 at a CAGR of 11.8% to touch USD 5.7 billion by 2030. The Cancer Registry Software Market is dominated by key players such as Cerner Corporation, McKesson Corporation, Epic Systems Corporation, GE Healthcare, Siemens Healthineers, IBM Watson Health, Allscripts Healthcare Solutions, Inc., Oracle Corporation, TruMed Systems, Cancer Registry Solutions, Intelerad Medical Systems, Oncology Systems, Inc., CloudMedx, Meditech, NantHealth.